Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108238 · ClinicalTrials.gov registry record · Phase 4
Estrogen Alternatives Study
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00108238: Completed Phase 4 study, sponsored by US Department of Veterans Affairs.
NCT00108238 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108238, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
Healthy postmenopausal women not currently taking hormone replacement or hormone modulating therapy take a 3-month course of estradiol/raloxifene/placebo to evaluate the effects of each on vascular function, as indicated by PET coronary flow reserve studies and brachial artery ultrasound, before and after use of the therapies. This is a randomized, placebo-controlled, blinded study.
Interventions
- DRUG Raloxifene
- DRUG Estradiol followed by progesterone
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-04 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
What the finished NCT00108238 record still lists
NCT00108238 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Raloxifene is the first listed.
NCT00108238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00108238 about?
NCT00108238 is a clinical study titled "Estrogen Alternatives Study". Healthy postmenopausal women not currently taking hormone replacement or hormone modulating therapy take a 3-month course of estradiol/raloxifene/placebo to evaluate the effects of each on vascular function, as indicated by PET coronary flow reserve studies and brachial artery ultrasound, before and...
What is the current status of trial NCT00108238?
This trial is currently completed. It is a Phase 4 study. The study started on 2003-04. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00108238?
The interventions under investigation include: Raloxifene (DRUG), Estradiol followed by progesterone (DRUG).
Who is sponsoring clinical trial NCT00108238?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia